Hospital Universitari Germans Trias i Pujol

hospital in Spain

Wikimedia Commons category is Hospital de Can Ruti


Coordinates:
(P625, lat/long)41.4808 / 2.23782

Hospital Universitari Germans Trias i Pujol is …
instance of (P31):
hospitalQ16917
medical organizationQ4287745

External links are
P968email addressgerencia.germanstrias@gencat.net
P2900fax number+34-934-97-88-43
P2671Google Knowledge Graph ID/g/121vxc2d
P12385Gran Enciclopèdia Catalana IDhospital-universitari-germans-trias-i-pujol
P1296Gran Enciclopèdia Catalana ID (former scheme)0522827
P2427GRID IDgrid.411438.b
P213ISNI0000000417676330
P856official websitehttp://www.gencat.cat/ics/germanstrias/
P402OpenStreetMap relation ID5678937
P1329phone number+34-934-65-12-00
+34-934-97-88-12
P3500Ringgold ID16514
P6782ROR ID04wxdxa47
P8082Spanish National Catalog of Hospitals ID080667
080667
P11686University of Barcelona authority ID981058544799906706
P214VIAF ID129686021

P1416affiliationAutonomous University of BarcelonaQ43452
P17countrySpainQ29
P571inception1983-01-01
P131located in the administrative territorial entityBadalonaQ15468
P6801number of hospital beds516
P137operatorInstitut Català de la SalutQ11926710
P749parent organizationInstitut Català de la SalutQ11926710
P580start time1983-04-14
P6375street addressCr Canyet, S/N

Wikimedia Commons Images

P18: image


FileName: Hospital Can Ruti.jpg

Description: Hospital Universitari Germans Trias i Pujol - Can Ruti.

Artist: Ottobdn

License: Public domain

Reverse relations

employer (P108)
Q90280294Adrià Plana Pla
Q89772177Agusti Barnadas
Q82622907Agusti Rodríguez-Palmero
Q49238802Aintzane Urbizu
Q86422160Alejandro Manzanares
Q57076258Alessandro Catanese
Q47158157Ana Lucía Arellano
Q97549270Ana Merino Ribas
Q57126614Andrea Colli
Q64008860Ane Jaka
Q57077202Antoni Matilla
Q56251614Antonio Heras
Q82657499Antonio Rodríguez-D'Jesús
Q50533133Aram Boada
Q91514105Ariadna Pérez-Ricart
Q88449395Carles Subirà
Q93193895Carlos Castaño Duque
Q92029762Carlos Puig-Jové
Q53179123Carlos Rodrigo
Q60655490Carmen Biosca
Q92090133Cesc Bertran-Cobo
Q79268207Cosme Garcia Garcia
Q87734050Cristian Carrasco-López
Q41531275Cristian Tebé
Q82998283Cristina Ibanez Esteves
Q51034795Cristina Ramo-Tello
Q73342460Daniel Escuin
Q57016359Daniel Fuster
Q56956489David Parés
Q30362226Didac Mauricio
Q58327339Dolores Álamo-Junquera
Q58283738Domingo Escudero
Q92589861Eduard Fernandez Nofrerías
Q87072219Eduard Pedemonte-Sarrias
Q41830346Elisabeth Castellanos
Q82292745Emma García-Melchor
Q62123867Esteban Reynaga
Q57416397Eva Martínez-Balibrea
Q50280630Eva Martínez-Cáceres
Q38798935Eva Montané
Q82563066Fernando Arméstar
Q100546827Ferran Rueda
Q64005420Giuseppe Lucente
Q55718159Guillem Pintos-Morell
Q84594414Helena Collgros
Q98574144Iara Da Silva
Q37378421Ignacio Blanco
Q94523888Ignasi Camps Ausàs
Q57161192Inés Velasco
Q89834193Irene Aldás
Q99610325Irene Espallargas
Q40808679Irene Latorre
Q100959278Ivan Hurtado
Q49832086Jaume Barallat
Q92288362Javier Corral
Q90944970Jesús Ribas
Q38546550Joan Carles Galcerán
Q67265581Joan Francesc Julián Ibañez
Q67558237Joan Verdaguer Autonell
Q104745457Jordi Bover
Q86187420Jose Vicente Hervas-Garcia
Q41691826Josep Lupón
Q37393125Josep M. Llovet
Q91596295José A Hernández-Hermoso
Q50202660José M. Balibrea
Q87734695José Manuel Carrascosa
Q55948645José Moltó
Q86484536Juan Colán-Hernández
Q88536024Juan José López
Q92023107Juan José Zamora-Sánchez
Q63924088Juan Luis Becerra
Q79682088Juan Manuel Leyva Moral
Q87413710Julia Canet-Pons
Q60315981Laia Gifre
Q98385273Laura Blanco
Q91795359Laura Soldevila
Q90433107Lidia Blay
Q63768173Lourdes Mateu
Q41090446Lílliam Flores
Q89298133Magí Farré
Q57338194Manuel Armengol
Q60533273Manuel Canal-Rivero
Q44011983Manuel Gómez-Choco
Q57571503Marc Sorigue
Q59667218Maria A Llopis
Q92180178Maria Bonjorn Juarez
Q104607290Maria Doladé
Q98187335Maria-Luisa Granada
Q89059933Mariusz Łucejko
Q101220609María Aparicio Espinar
Q57158302María Iglesias-González
Q90227743Max Hardy-Werbin
Q101220618Melania Martinez Morillo
Q100506281Miquel Gil Olaria
Q94462974Montserrat Guasch
Q90126924Montserrat Rovira Argelagués
Q88418452Míriam Mañosa Ciria
Q102217869Napoleón de la Ossa
Q24291756Oriol Mitjà Villar
Q114337191Oscar-Danilo Ortega-Hernandez
Q92154093Paloma Malagón-López
Q79898650Paloma Puyalto
Q90969786Patricia Echeverría
Q89275612Pedro Moliner-Borja
Q85371439Pere Vila Caral
Q16187422Pere-Joan Cardona i Iglesias
Q96247202Pilar Aparicio
Q88474875Ramiro Álvarez
Q57039309Ramon Romero
Q58878872Raquel Villar-Hernández
Q64706155Rosa Garcia Sanchez
Q55135625Ross D Cranston
Q83681398Samuel García-Reina
Q91793678Sandra Bonache
Q97433299Santiago Montero
Q98200344Sebastián Remollo
Q91208776Sergio Alonso-Fernández
Q98388608Sergio Marin
Q92153022Silvia Maya-Enero
Q98619071Silvia Reverté-Villarroya
Q87857146Sonia Sevilla Guerra
Q82886134Susana Santos-Ruiz
Q87642425Susanna Gassiot
Q89087477Sílvia Roure
Q59683393Vicente Ausina
Q42120755Vicente Lorenzo-Zúñiga
Q82051456Xavier Carrillo

place of death (P20)
Q117825244Josep Costa Font
Q11934943Manuel Cuyàs i Gibert

educated at (P69)
Q82622907Agusti Rodríguez-Palmero
Q92842032Alicia Garrido
Q47158157Ana Lucía Arellano
Q61767885Ana Marín-Sánchez
Q60655490Carmen Biosca
Q51034795Cristina Ramo-Tello
Q82292745Emma García-Melchor
Q62123867Esteban Reynaga
Q49832086Jaume Barallat
Q56939544Jaume Coll-Cantí
Q86187420Jose Vicente Hervas-Garcia
Q81101074José Luís Cuadra Urteaga
Q87837047Lorena Martín-Aguilar
Q57571503Marc Sorigue
Q71943825Merce Avellanet
Q90126924Montserrat Rovira Argelagués
Q102217869Napoleón de la Ossa
Q92154093Paloma Malagón-López
Q16187422Pere-Joan Cardona i Iglesias
Q88474875Ramiro Álvarez
Q89916152Robert Cilveti
Q74349921Sebastià J. Santaeugenia
Q98200344Sebastián Remollo
Q42120755Vicente Lorenzo-Zúñiga
Q55664892Xavier Soria

research site (P6153)
Q62104815"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
Q64794595A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Q63811701A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Q64220493A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)
Q65364903A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Q64353535A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
Q63320509A Phase IIa Study of NT-KO-003 for Multiple Sclerosis
Q66082259A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
Q62811890A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
Q64638737A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
Q63572072A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Q65364969A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Q63811891A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
Q63811716A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Q63592443A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Q64715171A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
Q65474364Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
Q63315792Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
Q64139511Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy
Q64710673Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning
Q66038405Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
Q66038404Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Q64607189An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)
Q63807993An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
Q64599278Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer
Q64623223Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations
Q63832484Anticoagulation in Stent Intervention
Q61918239Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
Q64635797Aspergillus PCR Early Detection in High Risk Oncohematological Patients
Q63316083Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
Q66039461Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
Q61981025Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Q63812630Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
Q65379596Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line Treatment in Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Q63573813Bowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study)
Q65539969Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Q65363116Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Q66082293Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain
Q64648084Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years
Q61956389Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Q64646942Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer
Q64646565Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D
Q62811342Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic
Q64614208Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
Q65379397Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers
Q64817491Clinical and Molecular Staging of Lung Cancer Stages I and IIp
Q63811512Comparative Study Between Conventional and Telematic Patients Follow-up
Q62031616Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
Q65368213Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
Q65474298Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Q64599156Diet for Colonoscopy Preparation in Diabetic Patients
Q65351761Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Q63335700Drug Interactions Between Echinacea Purpurea and Etravirine
Q64678486EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients
Q66067043Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain
Q64715386Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
Q65473310Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)
Q64042471Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis
Q65471177Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Q64354982Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
Q62054729Efficacy and Safety of a Simplification Treatment Based on Dolutegravir and Darunavir / Cobicistat vs Usual Treatment in Suppressed HIV-1-infected Patients With Multidrug Resistance.
Q64654934Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period
Q64697448Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Q63600002Efficacy of a Smartphone App for Chronic Pain Management
Q64640824Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours
Q65348854Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Q64697523Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Q66030728FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
Q61918213Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Q65474208Glivec in Ph Positive Lymphoblastic Leukemia
Q63400918Global Post-market Registry for the Treovance Stent-graft.
Q64719335HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
Q65377501High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3
Q61955738Home Telehealth Follow-up After Hospital Discharge for Chronic Obstructive Pulmonary Disease (COPD) Patients
Q63812335INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer
Q64720918Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
Q65380740Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
Q64598035Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients
Q64660548Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Q65355221Individualized Perioperative Open Lung Ventilatory Strategy
Q66042288Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation
Q64602660Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
Q64651544LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)
Q64652090Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed
Q105493630Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler
Q64649688Maraviroc Switch Collaborative Study
Q65384017Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
Q64664387Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent
Q64123777Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
Q63572991Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Q65365394Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
Q63399245Nordic and Spanish Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions With Myocardial Ischemia
Q65387716OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Q61966184Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation
Q63336106PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years
Q61917621PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Q64150211PH3 Study of Mirvetuximab Soravtansine vs Investigator's Choice of Chemotherapy in Women With FRa+ Adv. EOC, Primary Peritoneal or Fallopian Tube Cancer
Q66063177PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
Q64625185Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
Q63402264Parsaclisib in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)
Q65471056Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
Q64836727Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC
Q63831268Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery
Q64139628Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Q64354109Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma
Q64694268Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Q64718692Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
Q64794119Physiotherapy and Therapeutic Education on Patients With Pain Catastrophism Scheduled for a Total Knee Arthroplasty
Q64662036Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
Q63578810Population-based Study in Screening for Liver Fibrosis
Q65465905Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder
Q63397892Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study
Q64602638Pulmonary Embolism as a Cause of COPD Exacerbations
Q65382109QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
Q64655089R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial
Q63403760Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
Q64351601Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs
Q65373877Risk-adapted Therapy for Adult Acute Myeloid Leukemia.
Q61917558SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Q61918327SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
Q61980007Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)
Q66078728Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Q63575010Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Q63812466Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease
Q66032710Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)
Q63320259Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.
Q65470447Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments
Q64188156Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors
Q64795782Spanish Cohort of Patients With HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function
Q61907088Spanish Registry on Spontaneous Coronary Artery Dissection
Q64675336Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
Q65356334Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
Q64790062Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis
Q61939192Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Q63830391Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
Q65376625Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure
Q66039972Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Q64651888Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma
Q63575505Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors
Q66074490Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
Q106638192Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
Q63316079Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL
Q63818648Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
Q63320949Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically S
Q107169691Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
Q65331125Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues
Q96759577Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
Q65348661Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disop
Q66039776T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs
Q64718528TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.
Q65377677TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer
Q63582877Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock
Q65387141The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
Q61936877Third International Study on Mechanical Ventilation
Q63811776This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
Q63811774This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
Q106975759To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) (2021-06-30)
Q64353239Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Q64693789Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
Q65379371Treatment Insulin Resistence in HCV G-1 Patient
Q63319090Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
Q65473806Treatment of Acute Myeloblastic Leukemia in Younger Patients
Q61981020Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
Q64139680Treatment of High Risk Adult Acute Lymphoblastic Leukemia
Q65472914Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Q61980044Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
Q65382930Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Q64724117Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV
Q65363191Urban Training for COPD Patients
Q65473704VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Q65355512Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies
Q66047412Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Q65474257Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
Q64170787Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Q64720375ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)
Q106138919sFlt1/PlGF and Selective Labor Induction to Prevent Preeclampsia at Term

Q30287739Germans Trias i Pujol Research Instituteheadquarters locationP159
Q30254599IrsiCaixalocationP276
Q11926710Institut Català de la Saluthas subsidiaryP355
Q65157062Manuel Ribas Mundówork locationP937